What is QuidelOrtho Corporation's latin america — R&D?

QuidelOrtho Corporation (QDEL) reported latin america — R&D of $500K in Q1 2026.

How has QuidelOrtho Corporation's latin america — R&D changed year-over-year?

QuidelOrtho Corporation's latin america — R&D increased by 25.0% year-over-year, from $400K to $500K.

What does latin america — R&D mean?

Reflects the costs incurred for research and development activities specifically allocated to or supporting the Latin American segment's product portfolio. This investment indicates the company's commitment to regional product innovation and adaptation to local clinical requirements.

QuidelOrtho Corporation QDEL Latin America — R&D

Other segment segments

China

$700K-22.2%

EMEA

$400K-33.3%

North America

$400K0.0%

JPAC

$300K-25.0%

Similar metrics at other companies

AGCOLatin America — Engineering expenses

$12.7M+24.5%

BRCAmericas & Asia — R&D

$16.95M+27.3%

BCOLatin America — Capital Expenditures by Reportable Segment

$6.4M+6.7%

TFX

TFXAmericas — Research and development expenses

$14.25M+21.0%

AGCOLatin America — CapEx

$7M-14.6%

WTSAmericas — Research And Development Expense

$15.4M+12.4%

Other financials

Income statement

See full

Revenue$619.8M-10.5%

Gross profit$263.8M-23.2%

Operating income-$31.8M-198%

Net income-$91.8M-623%

EPS (diluted)-$1.35-611%

Balance sheet

See full

Cash & equivalents$140.4M+10.4%

Total debt$3.1B+0.3%

Total equity$1.9B-38.2%

Total assets$5.6B-12.9%

Cash flow

See full

Operating cash flow-$33.0M-150%

CapEx$34.0M-39.5%

Free cash flow-$67.0M-813%

Valuation

See full

Market cap$832.61M-56.1%

Enterprise value$3.8B-22.0%

P/S0.3×-0.4×

Profitability

See full

Gross margin45%-2.0pp

Operating margin-37%-46.2pp

Net margin-45.6%-75.7pp

FCF margin13.8%—

Returns & leverage

See full

Return on equity-49.9%-70.8pp

Debt / equity1.7×+0.6×

Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept qdel:SegmentInformationResearchAndDevelopmentExpense.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's latin america — r&d.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is QuidelOrtho Corporation's latin america — R&D?: QuidelOrtho Corporation (QDEL) reported latin america — R&D of $500K in Q1 2026.
How has QuidelOrtho Corporation's latin america — R&D changed year-over-year?: QuidelOrtho Corporation's latin america — R&D increased by 25.0% year-over-year, from $400K to $500K.
What does latin america — R&D mean?: Reflects the costs incurred for research and development activities specifically allocated to or supporting the Latin American segment's product portfolio. This investment indicates the company's commitment to regional product innovation and adaptation to local clinical requirements.